about
Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 SignalingAntioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of DesminopathyDiverse integrin adhesion stoichiometries caused by varied actomyosin activity.Two desmin gene mutations associated with myofibrillar myopathies in Polish familiesBAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndromeMyosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscleA novel dominant D109A CRYAB mutation in a family with myofibrillar myopathy affects αB-crystallin structure.Anesthetic considerations in myofibrillar myopathy.Mitochondrial abnormalities in the myofibrillar myopathies.FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency.Deficiency in Kelch protein Klhl31 causes congenital myopathy in mice.Rapid IFM Dissection for Visualizing Fluorescently Tagged Sarcomeric Proteins.New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.A novel mutation in the PDZ-like motif of ZASP causes distal ZASP-related myofibrillar myopathy.Pathology provides clarity in the next-generation sequencing era.Abnormal spontaneous activity in primary myopathic disorders.Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiencyNeuromuscular diseases with hypertrophic cardiomyopathy
P2860
Q28385823-3B1012EE-47B3-404C-AC94-17B151CAA3CCQ28547713-78B98716-AEB9-4EA7-A1C8-B7DDBC9B15DAQ30847509-50DE1542-E597-4D8F-A27D-F536FFEDD828Q34776342-0EB114CD-A705-4FD5-BADD-A1C495541756Q36605196-A4EE575D-D071-4375-9A43-317CB84F29A9Q36865114-E24C74F8-F8AD-4E4C-B1B0-00E20EBB03D7Q37442928-12408C91-8C9D-4F4B-9313-AC98A04233DEQ38248683-D838E7BF-64BB-4F01-AEE4-6AA4233B3903Q38552890-26AD767A-A244-4CF1-B9A5-CA4863372908Q41600270-64CA5DE3-F519-4F71-A16E-BD00C49CD344Q47246481-0D3D7757-D1DA-4293-8931-B31268512B2CQ49889301-331319E6-EC27-4BA2-85A9-B83DEBEF2331Q50449574-4245CF53-5E48-4A5B-9DF1-DED28D8C5ED1Q51558789-6E5DC435-1913-470B-A9A9-CAC17589CF70Q51690955-862C9DBA-89A8-495A-959B-6D889626EEDBQ52772920-98D83666-200A-44FC-97B5-6ABD99866918Q57651547-4D1970C2-CD2A-4216-8D4D-8369B4AC1E57Q58565564-AD4E9EC7-9D64-4B6A-9106-BDE3F50FB9D9
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Myofibrillar myopathies: new developments.
@ast
Myofibrillar myopathies: new developments.
@en
type
label
Myofibrillar myopathies: new developments.
@ast
Myofibrillar myopathies: new developments.
@en
prefLabel
Myofibrillar myopathies: new developments.
@ast
Myofibrillar myopathies: new developments.
@en
P2860
P1476
Myofibrillar myopathies: new developments
@en
P2093
Lev G Goldfarb
Rudolf A Kley
P2860
P304
P356
10.1097/WCO.0B013E328364D6B1
P50
P577
2013-10-01T00:00:00Z